Filing Details
- Accession Number:
- 0001209191-18-028124
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-04 16:39:24
- Reporting Period:
- 2018-05-02
- Accepted Time:
- 2018-05-04 16:39:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1293971 | Bluebird Bio Inc. | BLUE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1578696 | David Davidson | C/O Bluebird Bio, Inc. 60 Binney Street Cambridge MA 02142 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-05-02 | 13,000 | $24.47 | 37,905 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-05-02 | 1,100 | $173.25 | 36,805 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-05-02 | 1,000 | $174.41 | 35,805 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-05-02 | 1,703 | $175.61 | 34,102 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-05-02 | 1,000 | $176.55 | 33,102 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-05-02 | 3,299 | $177.90 | 29,803 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-05-02 | 1,200 | $179.00 | 28,603 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-05-02 | 698 | $179.56 | 27,905 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-05-02 | 3,000 | $180.04 | 24,905 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2018-05-02 | 13,000 | $0.00 | 13,000 | $24.47 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 27,000 | 2024-03-03 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2017.
- The range in prices for the transaction reported on this line was $172.95 to $173.85. The average weighted price was $173.2455. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $173.95 to $174.90. The average weighted price was $174.4050. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $175.20 to $175.95. The average weighted price was $175.6065. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $176.25 to $176.95. The average weighted price was $176.5456. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $177.45 to $178.40. The average weighted price was $177.8962. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $178.45 to $179.35. The average weighted price was $178.9958. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $179.45 to $179.70. The average weighted price was $179.5644. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $180.00 to $180.15. The average weighted price was $180.0358. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- This option vests over a four-year period, at a rate of twenty-five percent (25%) on January 1, 2015 and in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
